Ascentage Pharma Group International (6855.HK)

HKD 50.65

(11.32%)

Net Debt Summary of Ascentage Pharma Group International

Ascentage Pharma Group International's latest annual net debt in 2023 was 726.29 Million CNY , up 141.71% from previous year.
Ascentage Pharma Group International's latest quarterly net debt in 2024 Q2 was 578.92 Million CNY , down 0.0% from previous quarter.
Ascentage Pharma Group International reported annual net debt of 300.48 Million CNY in 2022, up 145.56% from previous year.
Ascentage Pharma Group International reported annual net debt of -659.53 Million CNY in 2021, down -33.32% from previous year.
Ascentage Pharma Group International reported quarterly net debt of 726.29 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Ascentage Pharma Group International reported quarterly net debt of 726.29 Million CNY for 2023 FY, up 141.71% from previous quarter.

Annual Net Debt Chart of Ascentage Pharma Group International (2023 - 2016)

Historical Annual Net Debt of Ascentage Pharma Group International (2023 - 2016)

Year	Net Debt	Net Debt Growth
2023	726.29 Million CNY	141.71%
2022	300.48 Million CNY	145.56%
2021	-659.53 Million CNY	-33.32%
2020	-494.7 Million CNY	36.66%
2019	-781.05 Million CNY	14.64%
2018	-915.04 Million CNY	-9121.45%
2017	-9.92 Million CNY	96.62%
2016	-293.69 Million CNY	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	578.92 Million CNY	0.0%
2023 Q4	726.29 Million CNY	0.0%
2023 FY	726.29 Million CNY	141.71%
2023 Q2	94.52 Million CNY	0.0%
2022 Q2	-137.48 Million CNY	0.0%
2022 Q4	300.48 Million CNY	0.0%
2022 FY	300.48 Million CNY	145.56%
2021 Q4	-659.53 Million CNY	0.0%
2021 FY	-659.53 Million CNY	-33.32%
2021 Q2	-435.6 Million CNY	0.0%
2020 FY	-494.7 Million CNY	36.66%
2020 Q2	-142.57 Million CNY	0.0%
2020 Q4	-494.7 Million CNY	0.0%
2019 Q2	-640.78 Million CNY	0.0%
2019 FY	-781.05 Million CNY	14.64%
2019 Q4	-781.05 Million CNY	0.0%
2018 Q4	-915.04 Million CNY	0.0%
2018 FY	-915.04 Million CNY	-9121.45%
2017 FY	-9.92 Million CNY	96.62%
2016 FY	-293.69 Million CNY	0.0%

Peer Net Debt Comparison of Ascentage Pharma Group International

Name	Net Debt	Net Debt Difference
Uni-Bio Science Group Limited	-76.36 Million HKD	1051.039%
CK Life Sciences Int'l., (Holdings) Inc.	5.26 Billion HKD	86.21%